Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $443.48MP/E –Yield –
Vireo Growth enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vireo Growth's enterprise value was $229.18M on Oct 19, 2026, against $105.45M a year earlier. Over the last 5 years it ranged from -$17.62M to $285.60M, with a median of $77.02M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $229.18M | +1.9% |
| 2025 | Dec 31, 2025 | $224.95M | +177.4% |
| 2024 | Dec 31, 2024 | $81.10M | +344.4% |
| 2023 | Dec 29, 2023 | $18.25M | -66.4% |
| 2022 | Dec 30, 2022 | $54.25M | -74.2% |
| 2021 | Dec 31, 2021 | $210.49M | – |
See a number that looks wrong?